Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis
Falling Knife setup
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $82.13, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: single source or limited number of sources; Thin upside margin: 8.0%.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products, sports medicine, extremities, trauma, and craniomaxillofacial products across Americas, EMEA, and Asia Pacific segments. It sells primarily to hospitals and surgeons via consignment (~85% of... Read more
Hold if already holding. Not a fresh buy at $82.13, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: single source or limited number of sources; Thin upside margin: 8.0%. Chart setup: Death cross, below all MAs, RSI 30, MACD bearish. Maintain position. Not compelling to add more. Score 5.7/10, moderate confidence.
Passes 4/7 gates (clean insider activity, no SEC red flags, earnings proximity 98d clear, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMSuppliermanufacturing concentrated in one or a few plants10-K Item 1A: 'the manufacturing of certain of our product lines is concentrated in one or a few plants which are concentrated in a single country or region'
- HIGHSuppliersingle source or limited number of sources10-K Item 1A: 'Certain of these materials and components and outsourced activities can only be obtained from a single source or a limited number of sources'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $82.13, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: single source or limited number of sources; Thin upside margin: 8.0%. Chart setup: Death cross, below all MAs, RSI 30, MACD bearish. Maintain position. Not compelling to add more. Target $88.67 (+8.0%), stop $77.44 (−6.1%), A.R:R 1.1:1. Score 5.7/10, moderate confidence.
Take-profit target: $88.67 (+8.0% upside). Target $88.67 (+8.0%), stop $77.44 (−6.1%), A.R:R 1.1:1. Stop-loss: $77.44.
Concentration risk — Supplier: single source or limited number of sources; Thin upside margin: 8.0%; Negative momentum.
Zimmer Biomet Holdings, Inc. trades at a P/E of 20.7 (forward 8.9). TrendMatrix value score: 7.9/10. Verdict: Hold.
34 analysts cover ZBH with a consensus score of 3.3/5. Average price target: $99.
What does Zimmer Biomet Holdings, Inc. do?Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products, sports medicine, extremities,...
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products, sports medicine, extremities, trauma, and craniomaxillofacial products across Americas, EMEA, and Asia Pacific segments. It sells primarily to hospitals and surgeons via consignment (~85% of 2025 net sales), with no individual customer exceeding 2% of net sales.